Dietary cholesterol supplementation and inhibitory factor 1 serum levels in two dizygotic Smith-Lemli-Opitz syndrome twins: a case report

[1]  Z. Korade,et al.  Identification and characterization of prescription drugs that change levels of 7-dehydrocholesterol and desmosterol[S] , 2018, Journal of Lipid Research.

[2]  A. Gnoni,et al.  Systematic review of plasma-membrane ecto-ATP synthase: A new player in health and disease. , 2018, Experimental and molecular pathology.

[3]  J. Ferrières,et al.  Serum inhibitory factor 1, high-density lipoprotein and cardiovascular diseases , 2017, Current opinion in lipidology.

[4]  Z. Korade,et al.  Probes for protein adduction in cholesterol biosynthesis disorders: Alkynyl lanosterol as a viable sterol precursor , 2017, Redox biology.

[5]  A. Gropman,et al.  A Placebo-Controlled Trial of Simvastatin Therapy in Smith-Lemli-Opitz Syndrome , 2016, Genetics in Medicine.

[6]  J. Cuezva,et al.  The ATPase Inhibitory Factor 1 (IF1): A master regulator of energy metabolism and of cell survival. , 2016, Biochimica et biophysica acta.

[7]  A. Thurm,et al.  Development, behavior, and biomarker characterization of Smith-Lemli-Opitz syndrome: an update , 2016, Journal of Neurodevelopmental Disorders.

[8]  D. Babovic‐Vuksanovic,et al.  Pregnancy in an individual with mild Smith–Lemli–Opitz syndrome , 2014, Clinical genetics.

[9]  B. Gerhartz,et al.  A quantitative homogeneous assay for fragile X mental retardation 1 protein , 2013, Journal of Neurodevelopmental Disorders.

[10]  J. Varga,et al.  Relation between biomarkers and clinical severity in patients with Smith–Lemli–Opitz syndrome , 2013, European Journal of Pediatrics.

[11]  R. Steiner,et al.  Treatment of Smith–Lemli–Opitz syndrome and other sterol disorders , 2012, American journal of medical genetics. Part C, Seminars in medical genetics.

[12]  R. Hennekam,et al.  Mutational spectrum of Smith–Lemli–Opitz syndrome , 2012, American Journal of Medical Genetics. Part C, Seminars in Medical Genetics.

[13]  M. Nowaczyk,et al.  Smith–Lemli–Opitz syndrome: Phenotype, natural history, and epidemiology , 2012, American journal of medical genetics. Part C, Seminars in medical genetics.

[14]  K. Koczok,et al.  Mutational Spectrum of Smith-Lemli-Opitz Syndrome Patients in Hungary , 2012, Molecular Syndromology.

[15]  S. Papa,et al.  Mitochondrial proteome analysis reveals depression of the Ndufs3 subunit and activity of complex I in diabetic rat brain. , 2012, Journal of proteomics.

[16]  A. von Eckardstein,et al.  The &bgr;-Chain of Cell Surface F0F1 ATPase Modulates ApoA-I and HDL Transcytosis Through Aortic Endothelial Cells , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[17]  J. Ruidavets,et al.  Mitochondrial Inhibitory Factor 1 (IF1) Is Present in Human Serum and Is Positively Correlated with HDL-Cholesterol , 2011, PloS one.

[18]  R. Shelton,et al.  Biological activities of 7-dehydrocholesterol-derived oxysterols: implications for Smith-Lemli-Opitz syndrome[S] , 2010, Journal of Lipid Research.

[19]  S. Papa,et al.  Effect of the ATPase inhibitor protein IF1 on H+ translocation in the mitochondrial ATP synthase complex. , 2009, Biochemical and biophysical research communications.

[20]  F. Porter.  Smith–Lemli–Opitz syndrome: pathogenesis, diagnosis and management , 2008, European Journal of Human Genetics.

[21]  D. S. Lin,et al.  Effects of Dietary Cholesterol on Plasma Lipoproteins in Smith-Lemli-Opitz Syndrome , 2004, Pediatric Research.

[22]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[23]  F. RivasCrespo,et al.  [Smith-Lemli-Opitz syndrome]. , 2001, Anales espanoles de pediatria.

[24]  F. Porter.  RSH/Smith-Lemli-Opitz syndrome: a multiple congenital anomaly/mental retardation syndrome due to an inborn error of cholesterol biosynthesis. , 2000, Molecular genetics and metabolism.

[25]  R. Steiner,et al.  Cholesterol supplementation with egg yolk increases plasma cholesterol and decreases plasma 7-dehydrocholesterol in Smith-Lemli-Opitz syndrome. , 2000, American journal of medical genetics.

[26]  R. Hennekam,et al.  The Smith-Lemli-Opitz syndrome , 2000, Journal of Medical Genetics.

[27]  I. Björkhem,et al.  Beneficial effects of dietary supplementation in a disorder with defective synthesis of cholesterol. A case report of a girl with Smith‐Lemli‐Opitz syndrome, polyneuropathy and precocious puberty , 1999, Acta paediatrica.

[28]  G. Utermann,et al.  Mutations in the Delta7-sterol reductase gene in patients with the Smith-Lemli-Opitz syndrome. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[29]  J. Mulvihill,et al.  Cholesterol and bile acid replacement therapy in children and adults with Smith-Lemli-Opitz (SLO/RSH) syndrome. , 1997, American journal of medical genetics.

[30]  V. P. Johnson,et al.  Treatment of Smith-Lemli-Opitz syndrome: results of a multicenter trial. , 1997, American journal of medical genetics.

[31]  G Salen,et al.  Clinical effects of cholesterol supplementation in six patients with the Smith-Lemli-Opitz syndrome (SLOS) , 1997, American journal of medical genetics.